DTRI-031

N/A

Report date: 2024/04/25 14:31:58
NME

Base Information

Drug NameDTRI-031
Drug Alias NameDTRI-031BB-031
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionVon willebrand factor inhibitors
TargetsVon willebrand factor
Therapy Area/IndicationsIschemic StrokeStrokePulmonary Embolism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBasking Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesBasking Biosciences Inc
Inactive CompaniesN/A
Active IndicationsIschemic StrokePulmonary Embolism
Inactive IndicationsStroke

Other Information

ATC CodeN/A
Related LinksN/A